Live Breaking News & Updates on Sharon Rosenzweig Lipson
Stay updated with breaking news from Sharon rosenzweig lipson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Epigenetic Technologies Find Clinical Applications genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
Cure for age-related blindness on horizon themunicheye.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themunicheye.com Daily Mail and Mail on Sunday newspapers.
AgeneBio Announces Completion of Patient Enrollment in Phase 2B Clinical Trial to Evaluate AGB101 to Treat Amnestic Mild Cognitive Impairment Due to Alzheimer s Disease - Topline results expected in November 2022 News provided by Share this article Share this article BALTIMORE, April 21, 2021 /PRNewswire/ AgeneBio announced today that it has completed enrollment in a Phase 2B clinical trial evaluating the efficacy of AGB101, a once-a-day investigational medication to treat amnestic Mild Cognitive Impairment due to Alzheimer s Disease (MCI due to AD). The clinical trial, known as HOPE4MCI (NCT03486938), is a 78-week study, randomized, double-blind, placebo controlled study that has enrolled 164 patients across 23 sites in the United States and Canada. ....